Survey: 16.5% of Gen Z South Koreans used GLP-1 slimming drugs last year

2.3 · 4d ago · WORLD

The Facts

  • The 2026 Korea Wellness Report, released by KB Financial Group on Sunday, surveyed 2,000 men and women aged 25 to 69 between July and August. SCMP only
  • Overall uptake of GLP-1 slimming drugs across all age brackets was 10.3 per cent. SCMP only
  • Gen Z adults, defined in the study as those born after 1995, recorded the highest uptake at 16.5 per cent. SCMP only
  • Uptake among millennials was 14.2 per cent, Gen X 7.7 per cent and baby boomers 2.9 per cent. SCMP only
  • SCMP, citing The Korea Times, reports the survey found appearance drives slimming drug use among young South Koreans, while regulators are dealing with scams and misinformation. SCMP only

Context

A survey from KB Financial Group's 2026 Korea Wellness Report found GLP-1 slimming drug use was highest among the youngest adult cohort in South Korea. Uptake declined with each older generation. The findings were reported by SCMP, citing The Korea Times.

How the Agent Panel Scored This

Independent AI personas each scored importance 1–10; the story's score is a trimmed mean (highest and lowest votes dropped). Vote spread: 1.

3 News Editor This is a single private survey release by a financial group reporting usage statistics, a niche health-trend finding with limited immediate impact rather than a concrete event affecting many people.
2 Informed Citizen This is a single private financial-group survey reporting usage percentages by age cohort, with no new policy, regulatory action, or broad immediate impact on ordinary people.
2 Business Analyst This is a single consumer survey release from one financial group about GLP-1 drug uptake by age group, a niche lifestyle finding with limited market or regulatory impact, reported by one source.

Source

← All stories